Mohammed Inayatullah Maula Ali

Mohammed Inayatullah Maula Ali is an Assistant Professor in the Department of Molecular Medicine at the Faculty of Health Sciences, University of Southern Denmark. His research focuses on tumor heterogeneity, drug resistance mechanisms in aggressive cancers, and the integration of single-cell multi-OMICS with computational and machine learning approaches for patient stratification.

• University: University of Southern Denmark
• School: Faculty of Health Sciences
• Department: Department of Molecular Medicine
• Position: Assistant Professor

His research interests center on understanding the molecular and cellular basis of cancer progression, particularly in ovarian and triple-negative breast cancer. He leverages advanced technologies such as single-cell RNA sequencing, epigenomic profiling, and gene regulatory network analysis to identify cell populations driving aggressiveness and therapy resistance. His work also extends to neuroimmunology, including the role of regulatory T cells in remyelination.

The recent publications highlight a strong trend in cancer genomics, epigenetic regulation, and immune signaling. Articles span topics from pan-cancer metastasis drivers to inflammasome activation via pathogen mimicry and T-cell aging in neurological repair. These studies employ high-throughput omics and computational modeling, emphasizing translational relevance in both oncology and regenerative medicine.

Mohammed Inayatullah Maula Ali has no listed scientific awards in the provided text.

There is no public information available regarding student advising or research grants. However, his extensive collaborative network, evident from co-authorship with international experts, suggests active engagement in large-scale research initiatives and potential supervision of trainees. His work is frequently highlighted in news outlets and academic platforms, indicating significant scientific impact.

While specific laboratory or research team details are not mentioned, his research fingerprint includes expertise in single-cell genomics, epigenetics, and computational biology, suggesting leadership or active participation in a multidisciplinary research group focused on molecular oncology and systems biology.